Key Highlights

  • Shares closed down 13.61% at $7.53, extending Thursday's after-hours decline.
  • The company's largest California contract fell to 3.5 stars from 4.0 for 2027, threatening 2028 quality Bonus payments.
  • The affected contract covers roughly 75% of the company's total membership.
  • The selloff was reinforced by fresh analyst downgrades and price-target cuts from several firms.
  • The company highlighted six other contracts rated 4.0 stars or better and continued expansion plans.

California Star Ratings Downgrade Drives the Selloff

Alignment Healthcare (NASDAQ:ALHC) shares closed sharply lower after the company's 2027 Centers for Medicare and Medicaid Services Star Ratings showed its largest California contract falling to 3.5 stars from 4.0, threatening eligibility for 2028 quality bonus payments. Alignment Healthcare is a technology-driven, consumer-centric Medicare Advantage insurer that offers plans to seniors, including the chronically ill and frail, across county-based markets in California, North Carolina, Nevada, Arizona, Florida, and Texas.

The affected contract covers roughly 75% of the company's total membership, making the ratings shift a significant financial setback given how closely Medicare Advantage reimbursement is tied to CMS Star performance.

Analyst Downgrades and Price-Target Cuts Compound the Decline

The selloff was reinforced by fresh downgrades and steep price-target cuts from several research firms, including BofA and William Blair, reflecting heightened concern over the financial impact of the lost quality-bonus eligibility on the company's largest contract.

Company Points to Other Contracts Rated 4 Stars or Better

Despite the downgrade on its largest contract, the company highlighted that six of its other contracts remain rated 4.0 stars or better, and it continues to pursue expansion plans in California and other core markets. Those details offered limited offset against today's sharp decline in market sentiment.

What Comes Next for Alignment Healthcare

Investors are likely to focus on how the company plans to address the downgraded contract ahead of 2028, along with any further detail on membership trends during the Medicare Advantage Annual Election Period beginning October 15.